Ur-Energy (NYSEAMERICAN: URG) is a small-cap company engaged in uranium exploration and production, primarily through its Lost Creek project in Wyoming. Analysts forecast substantial growth from its Shirley Basin project, with expectations for the company to achieve profitability by the second half of 2026. The International Atomic Energy Agency predicts a doubling of global nuclear capacity by 2050, enhancing uranium demand.
Grab Holdings (NASDAQ: GRAB), a leading Southeast Asian “super app” offering ride-hailing, delivery, and digital payments, has seen a decline of over 20% in stock value over the past year and approximately 30% in 2023. Despite being profitable, analysts suggest significant upside potential with price targets indicating potential recovery.
Aclaris Therapeutics (NASDAQ: ACRS) is focused on biotechnology with its lead candidate, bosakitug, currently in Phase 2 trials. With no market-ready products, the company relies on nominal licensing revenue but has garnered analyst support with a consensus price target suggesting more than 150% upside. ACRS has experienced a 200% increase over the past year, albeit on speculation.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
